Deciphering the clinical significance of longitudinal antiphospholipid antibody titers-Reference-Cited by-同舟云学术

Deciphering the clinical significance of longitudinal antiphospholipid antibody titers

Published:2024-03 Issue:3 Volume:23 Page:103510
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Chighizola Cecilia B.,Willis Rohan,Maioli Gabriella,Sciascia Savino,Andreoli Laura,Amengual Olga,Radin Massimo,Gerosa Maria,Atsumi Tatsuya,de Jesus Guilherme,Trespidi Laura,Branch D. Ware,Caporali Roberto,Andrade Danieli,Roubey Robert,Petri Michelle,Bertolaccini Maria Laura

Publisher

Elsevier BV

Reference110 articles.

1. 2023 ACR/EULAR antiphospholipid syndrome classification criteria;Barbhaiya;Ann Rheum Dis,2023

2. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS);Miyakis;J Thromb Haemost,2006

3. EULAR recommendations for the management of antiphospholipid syndrome in adults;Tektonidou;Ann Rheum Dis,2019

4. Fluctuation of anti-domain 1 and anti-Β2 glycoprotein I antibody titers over time in patients with persistently positive antiphospholipid antibodies;Chighizola;Arthritis Rheumatol,2023

5. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome;Pengo;J Thromb Haemost,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lupus and other autoimmune diseases: Epidemiology in the population of African ancestry and diagnostic and management challenges in Africa;Journal of Allergy and Clinical Immunology: Global;2024-11

2. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome;International Journal of Laboratory Hematology;2024-04-07

3. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects;Rheumatology Science and Practice;2024-02-29